Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder
Condition(s):Stress Disorders, Post-Traumatic; Stress Disorders, Traumatic, AcuteLast Updated:August 28, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Stress Disorders, Post-Traumatic; Stress Disorders, Traumatic, AcuteLast Updated:August 28, 2019Unknown status
Condition(s):Anxiety DisorderLast Updated:June 9, 2014Terminated
Condition(s):Stress Disorders, Traumatic, AcuteLast Updated:March 4, 2008Completed
Condition(s):Stress Disorders, Post-TraumaticLast Updated:December 14, 2015Completed
Condition(s):Acute Traumatic Stress Disorders; Post-Traumatic Stress DisordersLast Updated:March 4, 2008Completed
Condition(s):Acute Stress DisorderLast Updated:February 24, 2021Unknown status
Condition(s):Acute Stress DisorderLast Updated:September 19, 2022Completed
Condition(s):Acute Stress DisorderLast Updated:September 17, 2020Completed
Condition(s):Acute Stress DisorderLast Updated:March 18, 2014Completed
Condition(s):Stress Disorders, Post-TraumaticLast Updated:June 26, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.